- Investing Ideas
- Swiss Pharmaceuticals & Biotech Undervalued Dividend Payers
Swiss Pharmaceuticals & Biotech Undervalued Dividend Payers
Results
2
0 new
Companies available at a discount paying at least a 2% dividend yield.
2 companies
Roche Holding
Market Cap: CHF 293.5b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROG
CHF 367.80
7D
2.2%
1Y
23.3%
Tecan Group
Market Cap: CHF 1.8b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECN
CHF 137.90
7D
5.0%
1Y
-32.7%